- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 119 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 113 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 82 Pages
United States
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 117 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2048EUR$2,250USD£1,739GBP
- Report
- November 2023
- 124 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- August 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- February 2023
- 264 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- October 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,435GBP
- Report
- July 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,435GBP
- Report
- December 2021
- 120 Pages
Global
From €4050EUR$4,450USD£3,440GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more